Mitochondrial Ca 2 þ uptake controls cellular functions as diverse as aerobic metabolism, cytosolic Ca 2 þ signalling and mitochondrial participation in apoptosis. Modulatory inputs converging on the organelle can regulate this process, determining the final outcome of Ca 2 þ -mediated cell stimulation. We investigated in HeLa cells and primary skeletal myotubes the effect on Ca 2 þ signalling of the transcriptional peroxisome-proliferator-activated-receptor-c-coactivator-1a (PGC-1a), which triggers organelle biogenesis and modifies the mitochondrial proteome. PGC-1a selectively reduced mitochondrial Ca 2 þ responses to cell stimulation by reducing the efficacy of mitochondrial Ca 2 þ uptake sites and increasing organelle volume. In turn, this affected ER Ca 2 þ release and cytosolic responses in HeLa cells. Most importantly, the modulation of mitochondrial Ca 2 þ uptake significantly reduced cellular sensitivity to the Ca 2 þ -mediated proapoptotic effect of C 2 ceramide. These results reveal a primary role of PGC-1a in shaping mitochondrial participation in calcium signalling, that underlies its protective role against stress and proapoptotic stimuli in pathophysiological conditions.
Introduction
Calcium homeostasis is fundamental for cell metabolism, proliferation, differentiation and cell death, and extensive recent work has revealed a key role of intracellular organelles in its versatile regulation (reviewed in Berridge et al. 1 ). Elevation of intracellular Ca 2 þ concentration is dependent either on Ca 2 þ influx from the extracellular space through the plasmamembrane, or on Ca 2 þ release from intracellular Ca 2 þ stores, such as the endoplasmic/sarcoplasmic reticulum (ER/SR). Mitochondria are organized in a complex interconnected network all over the cell interior, and thus are able to form contacts with the different sources of Ca 2 þ (for recent reviews see Rizzuto et al. 2 
and Parekh 3
). These close contacts ensure the uptake of Ca 2 þ into the mitochondrial matrix, leading to three important consequences: (i) mitochondria function as cellular Ca 2 þ buffers, shaping the global cellular Ca 2 þ response; 4 (ii) Ca 2 þ entering into the mitochondrial matrix regulates mitochondrial metabolism; 5 (iii) the extent of mitochondrial Ca 2 þ load is a key determinant of the intrinsic apoptotic pathway, thus controlling cell fate under physiological and pathological conditions. 6 The composite Ca 2 þ uptake system of the mitochondrial membranes comprises the voltage-dependent anion channel of the outer membrane and the Ca 2 þ uniporter (mitochondrial Ca 2 þ uniporter (MCU)) in the inner membrane. 7, 8 Mitochondrial Ca 2 þ uptake is tightly dependent on the potential gradient (DC m ,BÀ180 mV, negative inside) of the inner mitochondrial membrane. In turn, DC m is determined by the activity of electron transport chain complexes, thus metabolic activity of the mitochondria determines also their Ca 2 þ uptake. Moreover, recent works demonstrated that morphological changes, such as fragmentation of the mitochondrial network also leads to changes of mitochondrial Ca 2 þ uptake through the modification of the spatial pattern of the intramitochondrial Ca 2 þ diffusion. 9, 10 Importantly, these changes in mitochondrial morphology are associated with the apoptotic processes 11 and they also modify the cellular sensitivity to Ca 2 þ -mediated apoptotic stimuli such as serum deprivation and oxidative stress (reviewed in Bianchi et al. 12 ). Recent studies identified fundamental molecular mechanisms of mitochondrial biogenesis, through the characterization of master genes determining the expression of mitochondrial proteins encoded in the nucleus of the cell (reviewed in Scarpulla 13 and Puigserver and Spiegelman 14 ). Among these, the peroxisome-proliferator-activated-receptor-g coactivator-1a (PGC-1a) displays several features of remarkable interest. First, by integrating the action of several transcription factors, it orchestrates the cellular response to changes in metabolic needs evoked by a number of physiological and pathological stimuli.
14 Indeed, cold exposure, fasting and exercise were shown to induce PGC-1a in a tissue-specific manner either through b-adrenergic stimulation or by Ca 2 þ /calmodulin-dependent protein kinase activation. 15, 16 PGC-1a stimulates mitochondrial biogenesis in concert with the increased expression of nuclear-encoded electron transport chain components, metabolic enzymes, and uncoupling proteins (UCPs 17 ). The latter effect includes partial mitochondrial uncoupling/depolarization and accounts for the adaptative thermogenic response in brown fat and skeletal muscle cells. 14 On the other hand, apart from its role in these physiological adaptation processes, recent observations suggest that the loss of function of PGC-1a leads to cellular dysfunction and increased sensitivity to apoptosis. PGC-1a null mice show neurodegenerative symptoms, associated with increased cell death in the striatal region of the brain. 18 Similarly, downregulation of PGC-1a in hypertrophic cardiac failure is responsible for apoptotic cell death of cardiac myocytes. 19, 20 These effects might due to impaired mitochondrial function, and imply a strong antiapoptotic effect of the protein. However, the mechanisms linking PGC-1a-induced mitochondrial changes to decreased susceptibility to cell death are unknown.
Altogether, these results prompted us to investigate the role of PGC-1a-induced changes in mitochondrial structure and function, particularly mitochondrial and Ca 2 þ homeostasis and apoptotic sensitivity, in different cellular models. In order to explore PGC-1a-induced changes, we combined population measurements and single cell imaging of organellar Ca 2 þ signals, using the differentially targeted Ca 2 þ -sensitive aequorin and ratiometric pericam probes, respectively. Furthermore, we assessed the role of PGC-1a-induced alteration of Ca 2 þ signalling to Ca 2 þ -dependent and -independent apoptotic stimuli.
Results

PGC-1a induces mitochondrial biogenesis and reduces mitochondrial calcium uptake in skeletal myotubes
To demonstrate the effect of PGC-1a on mitochondrial biogenesis we first used primary cultured rat skeletal myotubes. Primary non-differentiated myoblasts were transfected with PGC-1a, and after 5 days of differentiation overexpression of PGC-1a was verified by immunoblotting ( Figure 1a) . Immunofluorescence analysis showed a low endogenous level of PGC-1a in myotubes and a specific increase of nuclear staining of transfected cells, identified by coexpressed green fluorescent protein (GFP) (Figure 1b) . Further immunoblot analysis of PGC-1a-transfected myotube cultures demonstrated upregulation of PGC-1a target genes, such as nuclear respiratory factor-1 (NRF-1) in the cell nucleus and UCP-2 in mitochondria 21 (see Figure 1a) . Moreover, similar alteration of the expression profile of PGC-1a and its target genes could be induced by physiological induction of PGC-1a expression. Since PGC-1a was shown to be induced during adaptive thermogenesis through b-adrenergic stimulation of skeletal muscle to induce heat production, 17 primary myotubes were stimulated for 24 h with salbutamol (1 mM), a selective b 2 -adrenergic receptor agonist. Salbutamol treatment led to an B3-fold induction of PGC-1a and its target genes NRF-1 (B4-fold) and UCP-2 (B2.5-fold), comparable to the B2.5-fold increase achieved by its exogenous expression (Figure 1a) . Then we applied quantitative 3D digital microscopy 9 to quantify mitochondrial volume in control (mitochondrially targeted green fluorescent protein (mtGFP) transfected) and PGC-1a overexpressing myotubes (cotransfected with mtGFP and PGC-1a, Figure 1c ). Mitochondrial volume was imaged and quantified as percentage of the volume occupied by mitochondria (mtGFP-positive voxels in the 3D images), in randomly chosen cubic regions inside myotubes. Mitochondria occupied 16.371.26% of the intracellular volume of control cells, while the volume of mitochondria in PGC-1a overexpressing myotubes was almost doubled (Figure 1d , 26.871.69%, Po0.01). Thus, recombinant overexpression of PGC-1a in skeletal myotubes was capable of reproducing the complex phenotypic alteration of mitochondria typically induced by this master gene.
To investigate the consequences of these alterations on Ca 2 þ signalling, we carried out a series of experiments using specifically targeted aequorin probes: mitochondrially targeted mutated aequorin (mtAEQmut) for mitochondria, cytosolic aequorin (cytAEQ) for the cytosol, sarcoplasmic reticulum-targeted mutated aequorin (srAEQmut) for the SR. 22 Myotubes were stimulated with carbamylcholine (CCh, 500 mM) that acts on nicotinic acetylcholine (ACh) receptor of myotubes to induce Ca 2 þ influx and trigger Ca 2 þ -induced Ca 2 þ release from the SR. CCh was applied in the presence of the muscarinic ACh receptor (mAChR) blocker atropine (10 mM), in order to exclude any confounding effect of a mAChR response of the fibroblasts present in the cell culture. CCh stimulation caused a robust mitochondrial Ca 2 þ transient in control myotubes (peak value 121.77 15.8 mM), in agreement with previous results. 23 Interestingly, the maximal mitochondrial ([Ca 2 þ ] m ) response was attenuated by almost 50% in PGC-1a-overexpressing myotubes (63.277.6 mM, Po0.01 versus control, Figure 2a) . Similarly, b 2 -adrenergic receptor-driven induction of PGC-1a expression by salbutamol led to a reduction of mitochondrial Ca 2 þ uptake (83.3177.28 versus 10671.7 mM in controls, Po0.05, Figure 2b) Figure 3a) . Immunofluorescence experiments showed that PGC-1a was located to the nucleus in control and transfected HeLa cells (Figure 3b ). Notably however, the endogenous expression of PGC-1a was higher in HeLa cells with respect to primary cultured myotubes (compare Figure 3a and b with Figure 1a and b). Next, we examined mitochondrial morphology and histamine-induced Ca 2 þ signalling following transient overexpression of PGC-1a in HeLa cells. We carried out 3D quantitative imaging of mtGFP-transfected HeLa cells (controls) and of cells cotransfected with mtGFP and PGC-1a (PGC-1a-overexpressing cells), as described above. The results demonstrated that PGC-1a induces mitochondrial biogenesis also in this cell type, although to a lesser extent than in the primary myotubes. As shown in Figure 3c The effect of PGC-1a overexpression on mitochondrial Ca 2 þ accumulation was then investigated. Application of the IP 3 mobilizing agonist histamine (100 mM) to control HeLa cells induced a robust elevation in [Ca 2 þ ] m (peak value: 111.4713.2 mM), while in cells overexpressing PGC-1a the same stimulus elicited a markedly lower mitochondrial Ca 2 þ accumulation (peak value: 69.974.9 mM, Po0.01 versus control, Figure 3d ). These experiments showed that the primary effect of PGC-1a-induced mitochondrial biogenesis on the mitochondrial Ca 2 þ uptake rely on the organelle itself, independently of the source of Ca 2 þ signal.
Since mitochondrial Ca 2 þ uptake and IP 3 -induced Ca 2 þ release from the ER are tightly coupled, we investigated whether the observed changes in mitochondrial Ca 2 þ uptake was accompanied by alterations in cytosolic and ER Ca 2 þ signals. As measured in cell population with the cytAEQ probe, the amplitude of [Ca 2 þ ] c elevation in response to 100 mM histamine was slightly, but consistently reduced in PGC-1a-overexpressing cells. The peak value in controls transfected with cytAEQ was 2.2570.09 mM, while in PGC-1a-overexpressing cells, cotransfected with PGC-1a and cytAEQ was 1.9870.09 mM (Po0.05, Figure 3e ). Importantly, after 10 min preincubation with the mitochondrial uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, 10 mM), PGC-1a overexpression had no effect on [Ca Figure 4a and b).
Based on the above data we supposed that reduced mitochondrial Ca 2 þ uptake during fast Ca 2 þ release from the ER might be a result of the Ca 2 þ -mediated negative feedback on the IP 3 R as mitochondria fail to rapidly clear the high . Cells were stimulated with CCh (500 mM) where indicated, in the presence of the mAchR blocker atropine (100 mM). In (d), skeletal myotubes were transected with srAEQmut alone (control, black traces) or cotransfected with PGC-1a (grey traces). Ca 2 þ (1 mM) was added to induce refilling of the SR followed by tBHQ (100 mM) addition in order to measure the Ca 2 þ leak, after blocking the SERCA pumps. Data are representative of X12 traces obtained from at least three separate experiments PGC-1a and Ca 2 þ signalling K Bianchi et al efficiency of ER-mitochondrial Ca 2 þ signal transmission through the reduction of mitochondrial Ca 2 þ uptake.
PGC-1a reduces Ca 2 þ concentration reached in mitochondria through direct and indirect mechanisms
In order to investigate the mechanism by which PGC-1a exerts its effect on [Ca 2 þ ] m we carried out digital imaging of the mitochondrially targeted ratiometric pericam (2mtRP). 9 This method allowed the quantitative analysis of (i) the initial Ca 2 þ uptake (hot spots), representative of Ca 2 þ uniporter activity in the high [Ca 2 þ ] microdomains of ER Ca 2 þ release sites, and (ii) the average distance of the subsequent intramitochondrial Ca 2 þ diffusion, representing the volume in which intramitochondrial Ca 2 þ is distributed. First, we compared the kinetics of Ca 2 þ uptake (Figure 5b, upper panel) after 100 mM histamine stimulation in control (transfected with 2mtRP) and PGC-1a-overexpressing (2mtRP þ PGC-1a transfected) cells. Mitochondria of PGC-1a-overexpressing cells showed slower Ca 2 þ uptake kinetics, and reduced maximal mitochondrial Ca 2 þ response ( Figure 5b , upper panel), confirming the results obtained in population measurements using the mtAEQmut probe (see Figure 3d) . Then, in the same cells, we analysed the number of active Ca 2 þ uptake sites and the area of Ca 2 þ diffusion. These results showed that (i) the reduction in the initial Ca 2 þ uptake kinetics was due to the reduced number of Ca 2 þ uptake sites in PGC-1a-overexpressing cells (Figure 5b , middle panel), reflecting reduced Ca 2 þ uniporter activity at time points o1 s after stimulation; (ii) diffusion of Ca 2 þ waves to a longer distance during the peak phase of the mitochondrial Ca (Figures 1a  and 3a) Thus, we applied quantitative imaging of mitochondrial DC m in control and PGC-1a-overexpressing HeLa cells. Cells were loaded with the potential sensitive dye tetramethyl-rhodamine-methyl-ester (TMRM, 20 nM), and the steady-state intensity of the dye accumulated in the mitochondria was measured by confocal imaging. PGC-1a-overexpressing cells (cotransfected with GFP) showed a small (B4%) decrease of TMRM loading compared to controls (mean fluorescence intensity (AU): 1812716 in control, GFP-expressing cells versus 1731717 in PGC1a þ GFP-expressing cells, Po0.01, Figure 4f ). Since the MCU shows a steep voltage dependency, 7 even a small reduction of DC m may contribute to the observed reduction of mitochondrial Ca 2 þ uptake kinetics. However, it is unlikely that it fully accounts for the important inhibition of mitochondrial Ca 2 þ uptake caused by PGC-1a overexpression in HeLa cells. Thus, other effects of the transcriptional coactivator on the mitochondrial Ca 2 þ uptake machinery might be responsible for these changes (e.g. downregulation of the yet unidentified Ca 2 þ uniporter).
PGC-1a overexpression protects against Ca 2 þ -mediated cell death
Mitochondrial Ca 2 þ uptake has been shown to be a fundamental factor in the activation of the intrinsic apoptotic pathway and in sensitizing the response to several apoptotic stimuli (for recent reviews see Duchen 24 , Rizzuto et al. 25 and Orrenius et al. 26 ). Reduction of mitochondrial Ca 2 þ accumulation by PGC-1a thus might result in diminished cellular sensitivity to Ca 2 þ -mediated apoptosis. Therefore, we applied C 2 ceramide to induce apoptosis in HeLa cells, as it acts through mitochondrial Ca 2 þ overload and activation of the intrinsic apoptotic pathway following Ca 2 þ release from the ER. 6, 27 HeLa cells were transiently transfected with mitochondrially targeted DsRed alone (mtDsRed, controls) or in combination with PGC-1a (PGC-1a-overexpressing . After overnight incubation with C 2 ceramide and elimination of dead cells we observed a substantial increase in the proportion of PGC-1a-expressing cells after treatment (25.078.6% increase in PGC-1a/ mtDsRed-overexpressing cells versus À2.071.6% in control/mtDsRed-expressing cells, Po0.05, Figure 6a ). In this experimental setup positive changes in the percentage of surviving transfected cells indicates protection against the apoptotic stimulus by the overexpressed protein, while reduction provides evidence for its proapoptotic effect, 9 thus PGC-1a protected a significant number of cells from C 2 ceramide-induced apoptosis. Moreover, the effect was specific to mitochondrial Ca 2 þ -mediated apoptotic stimuli, since no increase in the survival of PGC-1a/mtDsRedexpressing cells was observed when apoptosis was induced by staurosporine, which activates the intrinsic apoptotic pathway in a largely independent way of mitochondrial Ca 2 þ uptake. These data were confirmed by quantifying nuclear condensation after Hoechst staining, representing and earlier phase of the apoptotic process. Cells were cotransfected with GFP and PGC-1a (PGC-1a-overexpressing cells). Cell death was induced by 40 mM C 2 ceramide and 1 mM staurosporine. After 3 h of treatment, cells were fixed, and the intensity of Hoechst-stained nuclei were quantified in transfected (GFP þ PGC-1a) and nontransfected cells. Hoechst intensity was significantly lower in PGC-1a-expressing cells, showing a specific protection against the apoptotic process (1070762 in PGC-1a/GFP-positive versus 1263760 in nontransfected cells, Po0.05, Figure 6b and c) . Interestingly, while staurosporine induced a stronger nuclear condensation, PGC-1a-expressing cells were partially protected in this phase of staurosporine-induced cell death (1620771 in PGC-1a/GFPpositive versus 1785745 in nontransfected cells, P ¼ 0.05).
These results provided evidence that the PGC-1a-induced reduction of mitochondrial Ca 2 þ uptake increases the threshold for Ca 2 þ -mediated apoptosis. This compound effect of PGC-1a provides a protective mechanism under stress conditions leading to Ca 2 þ mobilization and Ca 2 þ -mediated mitochondrial damage.
Discussion
In the past few years, mitochondria emerged as a central target of several cellular signalling routes including Ca 2 þ , apoptotic/necrotic and proliferative signalling pathways, determining cellular function and fate. Here we describe the mechanism by which the transcriptional coactivator PGC-1a, by inducing mitochondrial biogenesis and through direct inhibition of mitochondrial Ca 2 þ uptake modulates Ca 2 þ signalling and cellular apoptotic sensitivity. The site of PGC-1a action on Ca 2 þ homeostasis PGC-1a was originally identified as peroxisome-proliferatoractivated-receptor-g (PPAR-g) coactivator, responsible for adaptive thermogenesis by activating a complex transcriptional programme that leads to increased mitochondrial biogenesis and respiration, 17 and was thus identified as a mitochondrial 'master gene'. Further studies showed that it elicits a pleiotropic effect on metabolism and cellular differentiation including hepatic gluconeogenesis, 28 fatty acid oxidation 29 and type switch of muscle fibres, 30 effects comprising also extramitochondrial processes. Our finding that PGC-1a-overexpressing cells display a change in global cellular Ca 2 þ signalling may reflect these effects; however, the large reduction of mitochondrial Ca 2 þ accumulation together with the observed robust mitochondrial biogenesis rather points to a primary alteration in mitochondrial Ca 2 þ handling. This is further suggested by the fact that FCCP, a protonophore that suppresses DC m and consequently Ca 2 þ uptake, also reduced the [ Figure 4) . In contrast, the cytosolic Ca 2 þ transients in skeletal muscles were not affected by PGC-1a overexpression. This can be assumed to the compound cytosolic Ca 2 þ response of myotubes originating both from Ca 2 þ influx and Ca 2 þ release. Moreover, inactivation of ryanodine receptors starts only at around 50-100 mM [Ca 2 þ ]. 32 Thus, the Ca 2 þ increase caused by the reduction of mitochondrial Ca 2 þ uptake in the vicinity of ryanodine receptor may well be insufficient to inhibit channel activity.
The mechanism of PGC-1a-induced reduction of mitochondrial Ca 2 þ uptake Our experiments revealed two principal sites of action of PGC-1a on mitochondrial Ca 2 þ homeostasis. First, it inhibits mitochondrial Ca 2 þ uptake, as evidenced by the reduction in the kinetics of the mitochondrial Ca In skeletal myotubes, PGC-1a promotes both coupled and uncoupled respiration. 33 The first is due to the coordinated upregulation of mitochondrial respiratory chain and F 1 F 0 -ATPase complexes and the second to an increased expression of UCP-2. By promoting the entry of protons into the mitochondrial matrix, UCPs lower mitochondrial potential and thus reduce the driving force for mitochondrial Ca 2 þ influx. This mechanism provides a logical explanation for the reduced mitochondrial Ca 2 þ accumulation in skeletal muscle cells. Nevertheless in HeLa cells we observed a relatively small DC m reduction, suggesting that overexpression of UCPs do not contribute considerably to the observed inhibitory effect. (However, it should be remembered that Ca 2 þ fluxes through the MCU show a very steep dependence on DC m .) Thus, a possible explanation is that among the numerous gene products regulated by PGC-1a some are part of the mitochondrial Ca 2 þ uptake machinery. Further studies are needed to identify these potential targets of PGC-1a.
The second, indirect mechanism by which PGC-1a reduced the [Ca 2 þ ] achieved during the cellular Ca 2 þ signal is the increase of mitochondrial volume. In principle, this volume increase might lead to increased contact surface between mitochondria and ER. However, the digital imaging analysis of the mitochondrial Ca 2 þ transient showed that PGC-1a overexpression does not increase the functionally active Ca 2 þ uptake sites, as we observed a lower number of 'hot spots' during the whole period of mitochondrial Ca 2 þ uptake (see Figure 5 ). This mechanism thus allows to distribute the Ca 2 þ entered into the mitochondrial matrix in a larger space. Previously we have shown that intramitochondrial Ca 2 þ diffusion is necessary to reach the maximal Ca 2 þ load in the continuous mitochondrial network as fragmentation of mitochondrial network reduced the overall mitochondrial Ca 2 þ load. 9 In this study, we have shown that the opposite change, that is, that the expansion of space between Ca 2 þ uptake sites leads to a similar reduction of the [Ca 2 þ ] m peak/ plateau. These studies, together with two recent observations showing that perinuclear clustering of mitochondria modifies the capacitative Ca 2 þ influx 10 and that changes in mitochondrial movements regulates Ca 2 þ uptake in the organelle 34 provide strong evidence that the morphological plasticity of the mitochondrial network is an important regulatory component of the mitochondrial and cellular Ca 2 þ signalling.
PGC-1a regulates cellular sensitivity to apoptosis
Permeabilization of the outer mitochondrial membrane and consequent release of proapoptotic factors from the mitochondrial intermembrane space is an essential component of the intrinsic apoptotic pathway and serve also as an amplification loop in the extrinsic pathway (for recent reviews see Bianchi et al. load, protecting cells from Ca 2 þ -dependent apoptotic stimuli, however, the cellular regulation of this process is still under investigation. In the present work, we show that PGC-1a-induced mitochondrial changes accomplishes a strict physiological regulation of mitochondrial Ca 2 þ accumulation and consequently also of the Ca 2 þ -dependent apoptotic process. Staurosporine-induced cell death was also shown to be partially inhibited in Bax/Bak-deficient cells, 38 showing reduced steadystate [Ca 2 þ ] er and Ca 2 þ release. In our system, PGC-1a presumably protected HeLa cells against staurosporine-induced early apoptosis by interfering with this Ca 2 þ -dependent component of the intrinsic apoptotic pathway.
The transcriptional regulation achieved by the interaction of PGC-1a with PPAR-g has been shown to be involved in regulating cellular differentiation in different cell types. Moreover, PGC-1a-regulated mitochondrial and extramitochondrial processes play an important role in the adaptation of cellular phenotype to environmental and metabolic changes such as cold exposure and fasting. Along these lines, two recent important observation identified PGC-1a also as a regulator of cell death: the loss of the protein led to loss of striatal function in the brain 18 and its downregulation was shown to be responsible for apoptosis of cardiac myocytes. 20 A likely mechanism for this protection could be the known upregulation of UCPs by PGC-1a, and the consequent downregulation of mitochondrial ROS production, however, no direct experimental evidence supports such a role of PGC1a in the above pathological models.
In conclusion, we demonstrate that the complex programme activated by PGC-1a (mitochondrial biogenesis and modification of the protein repertoire of the organelle) modifies the responsiveness of mitochondria to cellular Ca 2 þ signals, and thus tunes Ca 2 þ -dependent organelle functions, such as the sensitivity to apoptotic stimuli. This novel mechanism may represent the basis of some of the recently identified effects of PGC-1a (e.g. neuroand cardiac protection) and the site of pharmacological intervention. The latter possibility, and the crosstalk with other signalling routes or pathophysiological events (e.g. ROS production) will be the subject of further studies.
Materials and Methods
Cell culture and transfection
Primary cultures of skeletal myotubes were prepared from newborn rats as previously described. 39 HeLa cells were kept in DMEM, supplemented with 10% FCS and seeded onto uncoated glass coverslips. Both cell types were transfected using the Ca 2 þ phosphate technique, 24 h (HeLa) or 48 h (myoblasts) after plating. Myotubes were differentiated on the day after transfection by replacing the incubation medium with DMEM containing 2% HS. For luminescence measurements, cells were transfected with 1 mg of the differentially targeted aequorins (cytosolic: cytAEQ, mitochondrial: mitAEQmut, ER: erAEQmut, SR: srAEQmut 22 alone (controls), or with 3 mg of human PGC-1a in pcDNA4/TO. After overnight incubation, cells were washed thoroughly with PBS and myoblasts were grown in DMEM supplemented with 2% horse serum to allow myotube formation.
Aequorin measurements
CytAEQ-, mtAEQmut-or erAEQmut-expressing cells were reconstituted with coelenterazine, transferred to the perfusion chamber, light signal was collected in a purpose-built luminometer and calibrated into [Ca 2 þ ] values as previously described. 22 All aequorin measurements were carried out in KRB containing 1 mM CaCl 2 (KRB/Ca 2 þ , Krebs-Ringer modified Buffer: 135 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 0.4 mM K 2 HPO 4 , 1 mM CaCl 2 , 5.5 mM glucose, 20 mM HEPES, pH ¼ 7.4).
Imaging procedures
For [Ca 2 þ ] c imaging, cells were loaded with 4 mM fura-2 AM for 30 min at 371C in KRB/Ca 2 þ solution. Cells were imaged using an inverted Zeiss Axiovert 200 M microscope (Carl Zeiss, Jena, Germany) using a 40 Â /1.3/ oil Fluar objective. Fura-2 fluorescence was measured at 340 and 380 nm excitation using a random access monochromator (Photon Technology International, NJ, USA) and emission was detected using a 505/30 emission filter. Images at 20-40 frame/s were acquired with a 512BFT Cascade camera (Princeton Instruments, AZ, USA) at 371C. Analysis was carried out using the MetaFluor Analyst software (Universal Imaging Corporation, PA, USA).
For [Ca 2 þ ] m imaging, HeLa cells were transiently transfected with the mitochondrially targeted Ca 2 þ -sensitive ratiometric pericam probe (2mtRP 40 )7PGC-1a. After 36 h of transfection, cells were placed in a thermostatted chamber at 371C in KRB/Ca 2 þ . Cells were imaged using an inverted Zeiss Axiovert 200 M microscope (Carl Zeiss, Jena, Germany) using a 63 Â /1.4/oil Plan-Apochromat objective. The 2mtRP probe was excited at 410 nm, using a random access monochromator (Photon Technology International, NJ, USA) and imaged with the 512BFT Cascade intensified camera at 20 frame/s. The first raw image of the time series was deconvolved using the no-neighbours algorithm (MetaMorph 5.0, Universal Imaging), and thresholded to create a binary mask. The mask was applied to dF/F images, calculated from the raw image series. Timederived images were calculated using the MetaFluor Analyst software of the Meta Imaging software package (Universal Imaging). Images were then transformed to a MetaMorph stack file, thresholded and subjected to integrated morphology analysis. Hot spots and diffusion area were calculated as total area of separated objects over a standard threshold applied for all images.
For 3D image acquisition the cells were transfected with mtGFP. Cells were imaged at 201C using an inverted Zeiss Axiovert 200 M microscope (Carl Zeiss, Jena, Germany) using a 63 Â /1.4/oil Plan-Apochromat objective, a CoolSNAP HQ interline CCD camera (Roper Scientific, NJ, USA) and the MetaMorph 5.0 software (Universal Imaging Corporation, PA, USA). Z-series images were deconvolved using the PSF-based Exhaustive Photon Reassignment deconvolution software, 41, 42 running on a Linux-based PC. For volume analysis the custom-made Data Analysis And Visualization Environment (DAVE) software was used. 42 For measurement of DC m cells were loaded with 10 nM TMRM for 30 min at 371C and steady-state intensity of the dye was quantified as previously described. 9 For quantifying nuclear condensation, cells were cotransfected with GFP and PGC-1a. After 3 h of C 2 ceramide (40 mM) or staurosporine (1 mM) treatment, cells were fixed (4% p-formaldehyde) and stained with 2 mM Hoechst 33342 for 30 min at 371C. Z-series of digital images were acquired (see above) at 360 nm (Hoechst) and 485 nm (GFP), and intensity was quantified on maximal projection images after background correction using the MetaMorph software (Universal Imaging Corporation, PA, USA).
Western blot and immunofluorescence analysis
HeLa cells and primary myotubes were plated in 35 mm well plates. After PGC-1a expression or salbutamol treatment cells were washed twice in PBS, trypsinized, pelleted (1000 rpm, 5 min, RT), resuspended and homogenized (10 mM NaCl, 10 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, protease inhibitor cocktail [Sigma-Aldrich], pH 7.4). Proteins were separated by SDS-PAGE on a 10% gel, and the amount of PGC-1a, UCP-2, NRF-1 and b-tubulin was estimated by Western blotting using polyclonal rabbit anti-PGC-1a (1 : 5000) goat anti-UCP-2 (1 : 3000) goat anti-NRF-1 (1 : 200) and monoclonal mouse anti-b-tubulin (1 : 5000) primary antibodies and respective HRP-labeled secondary antibodies (1 : 5000), according to standard protocols. All antibodies were from Santa-Cruz Biotechnologies, CA, USA. Immunofluorescence analysis was performed as previously described, 43 using the polyclonal rabbit anti-PGC1a (1 : 500) PGC-1a primary antibody, followed by the visualization with the AlexaFluor 549 anti-rabbit antibody (Invitrogen, Molecular Probest).
Data analysis
All data are expressed as mean7S.D. unless otherwise stated. Where appropriate, the Student's t-test was used for statistical evaluation.
